FDA 483 - Junopacific Inc. - January 24, 2025

An FDA inspection of Junopacific Inc., a medical device manufacturer in Minneapolis, revealed significant deficiencies in their quality system. The firm failed to adequately validate processes, including revalidation after a facility move, and did not properly control non-conforming products. These issues indicate a lack of adherence to established procedures and regulatory expectations for medical device manufacturing.